CIK: 0001056807 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $3,637,402 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 21,751,284 | $1,092,567 | 30.0% | $6.29 | +763.0% | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $207,504 | 5.7% | $32.15 | +11.3% | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 5,981,212 | $192,774 | 5.3% | $25.19 | +17.7% | COM | 76155X100 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3,922,413 | $124,968 | 3.4% | $23.91 | +6.7% | COM | 35104E100 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $110,866 | 3.0% | $18.98 | -58.1% | ORDINARY SHARES | G3855L106 |
| JANX | JANUX THERAPEUTICS INC | 2,919,818 | $109,931 | 3.0% | $15.21 | +43.2% | COM | 47103J105 |
| MIRM | MIRUM PHARMACEUTICALS INC | 4,370,024 | $109,775 | 3.0% | $27.38 | +0.4% | COM | 604749101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,755,990 | $108,661 | 3.0% | $17.69 | +53.8% | COM | 74366E102 |
| IONS | IONIS PHARMACEUTICALS INC | 2,428,613 | $105,280 | 2.9% | $39.42 | +20.9% | COM | 462222100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 9,135,893 | $103,418 | 2.8% | $37.66 | -65.7% | COM | 68062P106 |
| KURA | KURA ONCOLOGY INC | 4,786,293 | $102,092 | 2.8% | $13.94 | +39.5% | COM | 50127T109 |
| XOMA | XOMA CORP DEL | 3,633,743 | $87,392 | 2.4% | $15.57 | +43.9% | COM NEW | 98419J206 |
| CGON | CG ONCOLOGY INC | 1,884,191 | $82,716 | 2.3% | $40.84 | 0.0% | COM | 156944100 |
| TYRA | TYRA BIOSCIENCES INC | 4,661,194 | $76,444 | 2.1% | $16.23 | +1.1% | COM | 90240B106 |
| — | ESSA PHARMA INC | 8,748,629 | $74,276 | 2.0% | $3.65 | — | COM NEW | 29668H708 |
| ZYME | ZYMEWORKS INC | 5,870,000 | $61,752 | 1.7% | $7.03 | +58.0% | COM | 98985Y108 |
| GLPG | GALAPAGOS NV | 1,863,809 | $60,015 | 1.6% | $38.91 | — | SPON ADR | 36315X101 |
| CGEM | CULLINAN ONCOLOGY INC | 3,196,701 | $54,472 | 1.5% | $19.52 | -20.8% | COM | 230031106 |
| — | MERUS N V | 1,172,249 | $52,786 | 1.5% | $28.37 | — | COM | N5749R100 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,162,306 | $51,002 | 1.4% | $17.52 | +145.4% | COM | 45166A102 |
| ANNX | ANNEXON INC | 7,000,000 | $50,190 | 1.4% | $2.47 | +109.8% | COM | 03589W102 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $48,671 | 1.3% | $19.56 | — | COM | 760273102 |
| — | 89BIO INC | 4,047,354 | $47,111 | 1.3% | $13.02 | — | COM | 282559103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,875,000 | $44,625 | 1.2% | $15.37 | +45.1% | COM | 87164F105 |
| ACIU | AC IMMUNE SA | 14,571,236 | $43,131 | 1.2% | $4.93 | -27.3% | SHS | H00263105 |
| — | THIRD HARMONIC BIO INC | 4,365,933 | $41,214 | 1.1% | $16.07 | — | COM | 88427A107 |
| ENGN | ENGENE HOLDINGS INC | 2,251,037 | $38,155 | 1.0% | $10.40 | +17.7% | COM | 29286M105 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,521,948 | $35,994 | 1.0% | $9.95 | +104.0% | ORDINARY SHARES | N62509109 |
| GPCR | STRUCTURE THERAPEUTICS INC | 812,988 | $34,845 | 1.0% | $23.79 | — | SPONSORED ADS | 86366E106 |
| ROIV | ROIVANT SCIENCES LTD | 2,742,409 | $28,905 | 0.8% | $11.31 | -4.6% | SHS | G76279101 |
| — | GLYCOMIMETICS INC | 9,544,262 | $28,633 | 0.8% | $4.18 | — | COM | 38000Q102 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $23,736 | 0.7% | $2.68 | +134.8% | COM | 89854M101 |
| — | ALLAKOS INC | 16,552,417 | $20,856 | 0.6% | $3.39 | — | COM | 01671P100 |
| VSTM | VERASTEM INC | 1,685,219 | $19,886 | 0.5% | $6.94 | +66.5% | COM NEW | 92337C203 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $16,238 | 0.4% | $23.30 | — | SPONSERED ADS | 13124Q106 |
| CTMX | CYTOMX THERAPEUTICS INC | 6,595,801 | $14,379 | 0.4% | $5.34 | -65.4% | COM | 23284F105 |
| — | ELEVATION ONCOLOGY INC | 2,312,200 | $11,862 | 0.3% | $10.15 | — | COM | 28623U101 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $11,754 | 0.3% | $4.24 | -21.2% | COM | 690469101 |
| IMUX | IMMUNIC INC | 8,902,972 | $11,752 | 0.3% | $1.30 | 0.0% | COM | 4525EP101 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,000,000 | $10,560 | 0.3% | $3.78 | +27.1% | COM | 92840H400 |
| ELDN | ELEDON PHARMACEUTICALS INC | 4,326,710 | $8,913 | 0.2% | $6.12 | -70.8% | COM | 28617K101 |
| — | VERVE THERAPEUTICS INC | 650,000 | $8,632 | 0.2% | $34.35 | — | COM | 92539P101 |
| — | IKENA ONCOLOGY INC | 4,769,164 | $6,772 | 0.2% | $12.00 | — | COM | 45175G108 |
| — | CIDARA THERAPEUTICS INC | 6,861,127 | $6,312 | 0.2% | $2.37 | — | COM | 171757107 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $6,184 | 0.2% | $9.10 | — | COM | 92673K108 |
| DCTH | DELCATH SYS INC | 1,202,067 | $5,734 | 0.2% | $5.90 | -26.9% | COM NEW | 24661P807 |
| — | UNICYCIVE THERAPEUTICS INC | 3,611,601 | $4,984 | 0.1% | $1.08 | — | COM | 90466Y103 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $4,916 | 0.1% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $4,167 | 0.1% | $5.51 | 0.0% | COM NEW | 78397T202 |
| LXRX | LEXICON PHARMACEUTICALS INC | 1,686,924 | $4,049 | 0.1% | $2.49 | -13.8% | COM NEW | 528872302 |
| ANTX | AN2 THERAPEUTICS INC | 1,239,470 | $4,028 | 0.1% | $15.17 | -28.3% | COM | 037326105 |
| — | KRONOS BIO INC | 2,905,043 | $3,777 | 0.1% | $1.71 | — | COM | 50107A104 |
| — | PIERIS PHARMACEUTICALS INC | 20,609,863 | $3,776 | 0.1% | $0.87 | — | COM | 720795103 |
| — | VIRACTA THERAPEUTICS INC | 3,614,662 | $3,687 | 0.1% | $8.50 | — | COM | 92765F108 |
| IVA | INVENTIVA SA | 686,040 | $2,483 | 0.1% | $13.70 | — | ADS | 46124U107 |
| — | FORTE BIOSCIENCES INC | 2,982,105 | $2,090 | 0.1% | $0.66 | — | COM | 34962G109 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $1,720 | 0.0% | $19.71 | — | ADS | 60853G106 |
| — | MOLECULAR TEMPLATES INC | 522,238 | $1,170 | 0.0% | $6.32 | — | COM NEW | 608550208 |
| — | NLS PHARMACEUTICS LTD | 5,747,126 | $1,045 | 0.0% | $1.29 | — | SHS | H57830103 |
| — | ASLAN PHARMACEUTICALS LTD | 1,049,999 | $646 | 0.0% | $3.65 | — | SPON ADS NEW | 04522R200 |
| CRVS | CORVUS PHARMACEUTICALS INC | 361,406 | $643 | 0.0% | $5.07 | -58.8% | COM | 221015100 |
| RZLT | REZOLUTE INC | 190,815 | $487 | 0.0% | $19.25 | -92.6% | COM NEW | 76200L309 |